LAHELMA, Mari et al. Prognostic factors and overall survival among patients with ovarian cancer in the pre-PARP inhibitor era: the OCRWE-Finland study. Acta Oncologica, [S. l.], v. 63, n. 1, p. 763–771, 2024. DOI: 10.2340/1651-226X.2024.40324. Disponível em: https://medicaljournalssweden.se/actaoncologica/article/view/40324. Acesso em: 5 nov. 2024.